A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose.
- Yoshimi Tsuda
- , Christopher J. Parkins
- , Patrizia Caposio
- , F Feldmann
- , Sara Botto
- , Susan Ball
- , Ilhem Messaoudi
- , Luka Cicin-Sain
- , H Feldmann
- , Michael A. Jarvis*
*Corresponding author for this work
- Hokkaido University
- National Institutes of Health
- Oregon Health and Science University
- University of California at Riverside
- Helmholtz Centre for Infection Research
Research output: Contribution to journal › Article › peer-review